Legend Capital

Legend Capital is a Beijing-based venture capital firm and subsidiary of Legend Holdings. Founded in 2001, it focuses on early-stage and growth investments in technology-driven sectors with operations anchored in China and related markets. The firm backs companies in IT, internet applications and services, outsourcing, IC design and key components, as well as sectors such as telecommunications, media, healthcare, consumer and intelligent manufacturing. It manages multiple funds and actively supports portfolio companies with business development, market positioning and access to Chinese markets to create value. Legend Capital aims to back high-growth ventures and build lasting value in China's venture capital ecosystem.

Daqing Cai

Managing Director

Rui Chen

Managing Director

Chen Hao

Vice Chairman

FAN Qihui

Executive Director

Ge Xinyu

Managing Director

Frank Hong

Managing Director

Henry Haiquan Ji

Executive Director

Yi Kang

Director

Jiaqing Li

Managing Director

Richard Li

President

Joon Park

Managing Director

Zhenxing Shao

Partner / Managing Director

Jenking Shao

Managing Director and Partner

Piau-Voon Wang

Managing Director

Jeff Wang

Managing Director

Junfeng Wang

Managing Director

Nengguang Wang

Managing Director and CFO

Tony Wang

Managing Director and Vice President

William Wen

Executive Director

Hank Zhou Ph.D

Managing Director and Co-Chief Investment Officer

Quan Zhou

Managing Director, Partner

Hongbin Zhou

Managing Director

Linan Zhu

Chairman

Past deals in Chemical

Zhongke Guosheng

Series A in 2025
Zhongke Guosheng is research and development firm that designs and manufactures furan-based bio-based materials.

Zhongke Guosheng

Venture Round in 2024
Zhongke Guosheng is research and development firm that designs and manufactures furan-based bio-based materials.

Wepure

Seed Round in 2023
Wepure develops, manufactures, and distributes nano-microspheres made of silica gel and resin.

Zhongke Guosheng

Seed Round in 2022
Zhongke Guosheng is research and development firm that designs and manufactures furan-based bio-based materials.

Zhongke Guosheng

Angel Round in 2022
Zhongke Guosheng is research and development firm that designs and manufactures furan-based bio-based materials.

Bellen

Series B in 2017
Bellen Chemistry is a premier provider of a variety of heterocycles. Our activity is focused on the design and development of novel molecules,6361413375267061158256368.jpgintermediates for the Chemical and Pharmaceutical industries. Bellen Chemistryhas a strong R&D team with a talent pool of 200+ trained scientists. We have excellent track records, as we deliver unrivalled chemical innovation to our customers worldwide.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.